Update Email 25 Feb 2021

Greetings from Kimer Med.
We've had a productive week on the science front, including completing four different types of analysis of our antiviral protein, and a fifth is in progress. The results of these tests will be used to help inform our ongoing efforts to improve the fabrication process and product purity. We are currently using E. Coli bacteria to make the protein, although it's possible that will change at some point. Recombinant protein fabrication is a fascinating field!

Our fundraising efforts continue. If you'd like to support our work and help us move faster, here's a link to the donation page on our website:

Thanks for your continued interest.


Our vision is the end of viral disease in humans, pets and livestock.